Prescribing Trends of Oral Anticoagulants from 2010 to 2020 in Shanghai, China: A Retrospective Study.

Chi ZhangJia WangYa YangEr-Li MaHou-Wen LinBing-Long LiuZhi-Chun Gu

Published in: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis (2022)

There has been a rapid increase in the use of OAC over the last 11 years in Shanghai, China. NOACs have been adopted rapidly, and have been gradually replacing warfarin. Warfarin remains the top choice for certain patients with valvular heart disease. Future studies are warranted considering changes in the OAC use in a larger scale, as well as the rationality and its influence factors on OAC use.

Keyphrases

oral anticoagulants
atrial fibrillation
primary care
direct oral anticoagulants
pulmonary hypertension
current status
emergency department
decision making
venous thromboembolism
aortic valve
adverse drug
sensitive detection